Complete Filing Data
Prenetics Global Ltd reported Cash And Cash Equivalents of $52.25 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Prenetics Global Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Profit Loss | -$49.8M | -$64.8M | -$190.5M | -$174.0M | -$2.0M |
| Other Comprehensive Income | -$721.0K | $1.8M | -$4.8M | $260.1K | $1.6M |
| Comprehensive Income | -$50.5M | -$63.0M | -$195.3M | -$173.8M | -$382.5K |
| Research And Development Expense | $10.9M | $11.7M | $6.0M | $6.4M | $2.8M |
| Profit Loss From Operating Activities | -$48.1M | -$51.9M | -$66.0M | -$56.7M | -$995.1K |
| Profit Loss Before Tax | -$57.7M | -$56.7M | -$225.8M | -$216.6M | -$3.9M |
| Profit Loss Attributable To Owners Of Parent | -$46.3M | -$62.7M | -$190.5M | -$174.0M | -$1.9M |
| Profit Loss Attributable To Noncontrolling Interests | -$3.5M | -$2.1M | $0.00 | -$7.6K | -$24.2K |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$1.0M | $1.8M | -$4.8M | $260.1K | $1.6M |
| Income Tax Expense Continuing Operations | -$7.9M | -$269.0K | -$245.0K | $2.6M | -$1.9M |
| Gross Profit | $15.4M | $8.8M | $3.6M | $3.6M | $26.3M |
| Cost Of Sales | $15.2M | $12.9M | $9.5M | $8.9M | $38.8M |
| Comprehensive Income Attributable To Owners Of Parent | -$46.8M | -$61.1M | -$195.3M | -$173.7M | -$358.3K |
| Comprehensive Income Attributable To Noncontrolling Interests | -$3.7M | -$1.9M | $0.00 | -$7.6K | -$24.2K |
| Administrative And Other Operating Expenses | $46.7M | $41.4M | $59.3M | $47.9M | $16.6M |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Property Plant And Equipment | $558.0K | $331.0K | $268.0K | $476.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $52.3M | $45.7M | $146.7M | $35.3M | $14.5M | $11.5M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $1.0M | $345.0K | $4.9M | $8.5M | $2.9M | |
| Purchase Of Intangible Assets Classified As Investing Activities | $59.0K | $567.0K | $1.4M | $2.9M | $197.2K | |
| Cash Flows From Used In Operations | -$28.9M | -$12.6M | $14.6M | $13.4M | -$2.8M | |
| Cash Flows From Used In Operating Activities | -$28.9M | -$13.8M | $14.5M | $13.4M | -$2.9M | |
| Cash Flows From Used In Investing Activities | $38.5M | -$83.0M | -$46.1M | -$22.0M | -$6.0M | |
| Cash Flows From Used In Financing Activities | -$3.3M | -$4.7M | $143.3M | $29.3M | $11.8M | |
| Goodwill | $37.4M | $29.2M | $33.8M | $4.0M | $4.0M | |
| Current Contract Liabilities | $6.5M | $6.1M | $5.7M | $9.6M | $7.1M | |
| Adjustments For Increase Decrease In Trade Account Payable | -$4.7M | -$5.6M | -$2.6M | -$3.5M | $9.7M | |
| Adjustments For Increase Decrease In Deposits And Prepayments And Other Receivables | -$2.1M | $1.6M | -$1.2M | $6.1M | $1.1M | |
| Adjustments For Increase Decrease In Accrued Expenses And Other Current Liabilities | $854.0K | -$7.4M | -$24.4M | $27.4M | $6.0M | |
| Adjustments For Gain Loss On Disposals Property Plant And Equipment | -$2.0K | -$818.0K | -$73.0K | $39.00 | -$1.6K | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$563.0K | $37.6M | $7.0M | -$24.1M | -$20.1M | |
| Adjustments For Decrease Increase In Other Noncurrent Assets | -$427.0K | $535.0K | $431.0K | -$500.0K | -$32.6K | |
| Gains Losses On Change In Fair Value Of Financial Liabilities | $0.00 | $0.00 | -$60.1M | -$125.4M | ||
| Adjustments For Increase Decrease In Receivables From Related Companies | $3.0K | -$5.0K | $9.0K | -$9.1K | ||
| Payment For Acquire Financial Assets At Fair Value Through Profit Or Loss | $10.0M | $20.0M | $10.0M | |||
| Intangible Assets Other Than Goodwill | $11.6M | $13.4M | $14.8M | $23.8M | ||
| Cash Advances And Loans From Related Parties | $0.00 | $0.00 | -$128.8K | $4.5K | ||
| Gains Losses On Change In Fair Value Of Financial Assets At Fair Value Through Profit Or Loss | -$7.1M | -$9.4M | -$94.0K | |||
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | $8.3M | $0.00 | $3.4M | $0.00 | $2.9M | |
| Trade And Other Current Payables To Trade Suppliers | $3.7M | $1.7M | $7.3M | $10.0M | ||
| Reserves And Retained Earnings | $170.4M | $206.3M | $237.1M | -$400.8M | ||
| Other Noncurrent Assets | $1.4M | $743.0K | $1.3M | $693.5K | ||
| Noncurrent Liabilities | $5.7M | $4.5M | $11.5M | $490.7M | ||
| Noncurrent Lease Liabilities | $3.0M | $867.0K | $3.8M | $3.6M | ||
| Noncurrent Assets | $127.4M | $160.5M | $70.3M | $41.6M | ||
| Liabilities | $42.2M | $44.0M | $68.7M | $549.4M | ||
| Equity Attributable To Owners Of Parent | $170.4M | $206.4M | $237.1M | -$400.8M | ||
| Equity And Liabilities | $213.6M | $254.2M | $312.1M | $148.5M | ||
| Deferred Tax Assets | $0.00 | $28.0K | $243.4K | $79.7K | ||
| Current Trade Receivables | $5.2M | $4.1M | $41.7M | $47.0M | ||
| Current Tax Liabilities Current | $13.0K | $7.4M | $8.6M | $1.2M | ||
| Current Liabilities | $36.6M | $39.5M | $57.2M | $58.7M | ||
| Current Lease Liabilities | $2.8M | $1.5M | $2.9M | $1.7M | ||
| Current Assets | $86.1M | $93.7M | $241.8M | $106.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $42.0K | $99.0K | $50.0K | $713.5K | $10.9K |
| Payments Of Interest On Lease Liabilities Classified As Financing Activities | $203.0K | $241.0K | $244.0K | $205.9K | $49.4K |
| Payments Of Capital Element Of Lease Liabilities Classified As Financing Activities | $2.6M | $3.2M | $1.9M | $1.3M | $610.9K |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $6.3M | -$101.4M | $111.7M | $20.7M | $3.0M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $221.0K | $467.0K | -$317.0K | $87.2K | -$19.9K |
| Proceeds From Issue Of Bonds Notes And Debentures | $0.00 | $0.00 | $5.0M | $12.5M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-3.71 | $-5.58 | $-37.57 | $-178.81 | $-0.15 |
| Basic Earnings Loss Per Share | $-3.71 | $-5.58 | $-37.57 | $-178.81 | $-0.15 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Increase Decrease Through Sharebased Payment Transactions | $7.8M | $10.6M | $31.6M | $22.5M | $1.6M |
| Selling And Distribution Expenses | $8.6M | $8.2M | $4.7M | $5.7M | $6.5M |
| Other Gains Losses | $2.7M | $4.5M | $430.0K | -$202.2K | -$315.4K |
| Interest Received Classified As Investing Activities | $2.0M | $3.9M | $472.0K | $4.0K | $8.0K |
| Interest Paid Classified As Financing Activities | $0.00 | $0.00 | $173.0K | $33.00 | $654.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $119.0K | $821.0K | $226.0K | -$285.0K | $280.4K |
| Adjustments For Sharebased Payments | $7.8M | $10.6M | $31.6M | $22.5M | $1.6M |
| Adjustments For Interest Income | $2.0M | $3.9M | $472.0K | $4.0K | $8.0K |
| Adjustments For Depreciation Expense | $4.0M | $5.9M | $6.0M | $4.3M | $1.3M |
| Adjustments For Decrease Increase In Inventories | $1.3M | -$1.7M | $1.3M | -$2.3M | -$3.7M |
| Adjustments For Amortisation Expense | $1.9M | $1.9M | $1.6M | $3.1M | $1.1M |
| Adjustments For Fair Value Gains Losses | $0.00 | $0.00 | $29.1M | $2.8M | |
| Other Finance Cost | $203.0K | $120.0K | $4.0M | $5.1M | $59.6K |
| Increase Decrease Through Vesting Of Share Based Payment Transactions | $116.9K | $4.5K | $48.6K | ||
| Noncontrolling Interests | $957.0K | $3.8M | $6.4M | -$85.0K | |
| Issued Capital | $19.0K | $18.0K | $13.7K | $1.5K | |
| Inventories | $6.6M | $3.1M | $4.5M | $6.8M |
Most recent annual filing with the SEC: April 30, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.